Font Size: a A A
Keyword [Non - small cell lung cancer]
Result: 161 - 180 | Page: 9 of 10
161. Anti-Paclitaxel Resistance Effect Of Somatostatin Receptors Mediated Targeted Therapy On Non-small Cell Lung Cancer Cells And Its Possible Mechanisms
162. Functional Imaging And Proteomics Techniques Predict Sensitivity To Chemoradiotherapy In Non-Small Cell Lung Cancer
163. Combined Epidermal Growth Factor Receptor Targeting With The Tyrosine Kinase Inhibitor And The Monoclonal Antibody In No-Small Cell Lung Cancer
164. Effects And Mechanisms Of Combined Treatment With Everolimus And Gefitinib On Non-small Cell Lung Cancer Cell Lines
165. Clinical Relevance And Underlying Mechanism Of Altered Expression Of Proto-oncogene BCL11A In Non-small Cell Lung Cancer
166. The Antitumor Activity Of A Novel Dual PI3Kα/mTOR Inhibitor PI-103 In Cancer Therapy
167. Anticancer Activity And Mechanism Of Natural And Target-designed Small Molecule Compounds On Non-small Cell Lung Cancer
168. Study On Human Non-small Cell Lung Cancer-related Free Proteins
169. Study Of P190-B RhoGAP On Clinicopathologic Features And Prognosis In Patients With Non-Small Cell Lung Cancer
170. Effects Of Lentivirus Vector-mediated RNA Interference On Multi-drug Resistance In Non Small Cell Lung Cancer
171. The Relationship Of The MTOR Signal Pathway And The Diagnosis Of Non-small Cell Lung Cancer
172. The Role Of Fascin-1 In The Migration, Invasion And Proliferation Of Non Small Cell Lung Cancer
173. Study Of Expression Of Vascular Endothelial Growth Factor C Mrna In Non-Small Cell Lung Cancer And The Action Of Its Antisenseoligodeoxyribonucleotid On Lung Carcinoma Cell
174. Influence Of Interleukin 1 Beta Genetic Polymorphism, Smoking And Alcohol Drinking On The Risk Of Non-small Cell Lung Cancer
175. The Role Of Different Activated Macrophage Sub-phenotypes In Immune Escape Of Non-small Cell Lung Cancer
176. Gefitinib Resistance In Non Small Cell Lung Cancer With Active EGFR Mutations And Potential Therapeutic Significance Of Cytokine Induced Killer Cells
177. Screening Natural Small Molecule Inhibitor Of Non-Small Cell Lung Cancer And Studying Of Its Mechanisms
178. MicroRNA-101 Exerts Tumor-Suppressive Functions In Non-small Cell Lung Cancer Through Directly Targeting Enhancer Of Zeste Homolog 2 (EZH2)
179. The Clinical Research Of Compound Kusheng Injection In Combination With 3DCRT And Paclitaxel Treatment Locally Advanced Non-small Cell Lung Cancer
180. Relationship Of FA Pathway Dysfunction And Cisplatin Sensitivity In Non-small-cell Lung Cancer
  <<First  <Prev  Next>  Last>>  Jump to